Outcome | Group | Events | Total | Proportion (95% CI) | Heterogeneity (I2) |
---|---|---|---|---|---|
AE | IFX SC | 52 | 78 | 0.67 (0.56-0.76) | 0% |
VDZ | 350 | 543 | 0.64 (0.60-0.68) | 44% | |
SAE | IFX SC | 9 | 78 | 0.12 (0.06-0.21) | 0% |
VDZ | 59 | 543 | 0.11 (0.09-0.14) | 0% | |
Infection | IFX SC | 24 | 78 | 0.31 (0.22-0.42) | 0% |
VDZ | 139 | 543 | 0.26 (0.22-0.29) | 14% | |
Serious infection | IFX SC | 5 | 78 | 0.06 (0.03-0.14) | 35% |
VDZ | 9 | 489 | 0.02 (0.01-0.03) | 0% | |
Discontinuation due to AEs | IFX SC | 2 | 78 | 0.03 (0.01-0.10) | 0% |
VDZ | 31 | 667 | 0.05 (0.03-0.07) | 0% |